ArticleFrontiers in endocrinology2020

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease.

Aleksandra Furtak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.